Calcium Boosts Bisphosphonate Effects on Breast Cancer Cells
Author Information
Author(s): Fabrice Journé, Naïma Kheddoumi, Carole Chaboteaux, Hugues Duvillier, Guy Laurent, Jean-Jacques Body
Primary Institution: Institut Jules Bordet, Université Libre de Bruxelles
Hypothesis
Does extracellular calcium enhance the antitumor activity of bisphosphonates in breast cancer cells?
Conclusion
Extracellular calcium significantly increases the growth inhibition and apoptosis of breast cancer cells induced by bisphosphonates.
Supporting Evidence
- Calcium levels from 0.6 to 2.0 mmol/l were tested for their effects on breast cancer cells.
- High calcium concentrations significantly increased the growth inhibition caused by ibandronate.
- Calcium chelation reduced the effectiveness of ibandronate, indicating a direct relationship.
- Similar effects were observed in multiple breast cancer cell lines, not just MDA-MB-231 and MCF-7.
Takeaway
When there's more calcium around, breast cancer cells are more affected by certain drugs that help stop their growth.
Methodology
The study examined the effects of varying calcium levels on the activity of ibandronate in breast cancer cell lines using cell growth assays and apoptosis detection.
Limitations
The study primarily focused on in vitro conditions, which may not fully replicate in vivo environments.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website